Advanced Search
WANG Tao, ZHOU Zhixing, LIU Wei, JIANG Zhenzhou, ZHAO Guolin, SHANG Jing, ZHANG Luyong. Effects of colchicine on cholestatic liver injury in rats induced by bile duct ligation[J]. Journal of China Pharmaceutical University, 2014, 45(6): 715-719. DOI: 10.11665/j.issn.1000-5048.20140618
Citation: WANG Tao, ZHOU Zhixing, LIU Wei, JIANG Zhenzhou, ZHAO Guolin, SHANG Jing, ZHANG Luyong. Effects of colchicine on cholestatic liver injury in rats induced by bile duct ligation[J]. Journal of China Pharmaceutical University, 2014, 45(6): 715-719. DOI: 10.11665/j.issn.1000-5048.20140618
shu

Effects of colchicine on cholestatic liver injury in rats induced by bile duct ligation

More Information
    Graphical Abstract
    • Abstract
  • To investigate the effects of colchicine on the cholestasis in rats induced by bile duct ligation(BDL), colchicine(0. 12 and 0. 24 mg/kg)was administered intragastrically for 7 consecutive days after ligation of common bile duct. The effect of colchicines on the liver injury was evaluated by serum biochemistry(ALT, AST, ALP, γ-GTP, TBIL, DBIL, ALB and TBA), liver myeloperoxidase(MPO)activity as well as histological examination. Both doses of colchicine significantly decreased serum ALP, γ-GTP and TBA levels, inhibited liver MPO activity and alleviate liver histological changes, such as inflammatory cell infiltration and interlobular bile duct hyperplasia. Data suggested that lower dose of colchicines(≤0. 24 mg/kg)exerted protection of bile duct injury induced by BDL in rats involving primary mechanism on inhibiting activation and infiltration of inflammatory cells.
    • FullText(HTML)
    • References (13)
  • [1]
    Yamazaki M,Miyake M,Sato H,et al.Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats[J].Toxicol Appl Pharmacol,2013,268(1):79-89.
    [2]
    Roma MG,Toledo FD,Boaglio AC,et al.Ursodeoxycholic acid in cholestasis:linking action mechanisms to therapeutic applications[J].Clin Sci(Lond),2011,121(12):523-544.
    [3]
    Pan XF,Zhang CF,Chen XF.Clinical observation on the treatment with colchicin for icteric hepatitis[J].Mil Med J Southeast China(东南国防医药),2007,9(6):415-416.
    [4]
    Zhou ZX,Wang T,Jiang ZZ,et al.Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats[J].Arzneimittelforschung,2011,61(3):173-179.
    [5]
    Crocenzi FA,Sisti A,Pellegrino JM,et al.Role of bile salts in colchicine-induced hepatotoxicity.Implications for hepatocellular integrity and function[J].Toxicology,1997,121(2):127-142.
    [6]
    Rao CV,Mehendale HM.Effect of colchicine on hepatobiliary function in CCl4 treated rats[J].Biochem Pharmacol,1991,42(12):2 323-2 332.
    [7]
    Chen XM,Liu J,Wang T,et al.Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways[J].Toxicol In Vitro,2012,26(5):649-655.
    [8]
    Song JP,Wang T,Chen XM,et al.Study of the mechanism of liver injury induced by colchicin[J].Chin Pharmacol Bull(中国药理学通报),2011,27(7):1 019-1 023.
    [9]
    Mourelle M, Meza MA. Colchicine prevents D-galactosamine-induced hepatitis[J].J Hepatol,1989,8(2):165-172.
    [10]
    Muriel P,Quintanar ME,Perez-Alvarez V.Effect of colchicine on acetaminophen-induced liver damage[J].Liver,1993,13(4):217-221.
    [11]
    Allen K,Jaeschke H,Copple BL.Bile acids induce inflammatory genes in hepatocytes:a novel mechanism of inflammation during obstructive cholestasis[J].Am J Pathol,2011,178(1):175-186.
    [12]
    Allen K,Kim ND,Moon JO,et al.Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling[J].Toxicol Appl Pharmacol,2010,243(1):63-67.
    [13]
    Somi MH,Kalageychi H,Hajipour B,et al.Lipoic acid prevents hepatic and intestinal damage induced by obstruction of the common bile duct in rats[J].Eur Rev Med Pharmacol Sci,2013,17(10):1 305-1 310.
    • Related Articles

  • Related Articles

    [1]NING Manru, XU Kehui, HANG Taijun, SONG Min. Separation and identification of folic acid and its related substances by liquid chromatography-mass spectrometry[J]. Journal of China Pharmaceutical University, 2025, 56(1): 56-64. DOI: 10.11665/j.issn.1000-5048.2024052201
    [2]XIA Ying, LONG Jiayi, DAI Haoran, SHEN Mengyuan, GUO Hongli, HU Yahui, CHEN Feng. Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients[J]. Journal of China Pharmaceutical University, 2021, 52(6): 719-724. DOI: 10.11665/j.issn.1000-5048.20210610
    [3]XIA Ying, GUO Hongli, HU Yahui, CHEN Feng. Therapeutic drug monitoring for monoclonal antibody：progress in the application of LC-MS/MS technique[J]. Journal of China Pharmaceutical University, 2021, 52(1): 122-128. DOI: 10.11665/j.issn.1000-5048.20210117
    [4]NI Yueling, HAN Xing, SONG Min, HANG Taijun. Identification of the related substances of cyclosporin A by LC-MS techniques[J]. Journal of China Pharmaceutical University, 2019, 50(4): 423-437. DOI: 10.11665/j.issn.1000-5048.20190407
    [5]LIANG Fangmei, NI Yueling, WANG Lu, HANG Taijun, SONG Min. Structural identification of the related substances of fusidic acid by LC-MS[J]. Journal of China Pharmaceutical University, 2018, 49(3): 322-332. DOI: 10.11665/j.issn.1000-5048.20180311
    [6]LIU Chaoyi, ZHANG Ge, HANG Taijun, WANG Lei, ZHANG Xiaofei, SONG Min. Identification of related substances in rivaroxaban by LC-MS[J]. Journal of China Pharmaceutical University, 2015, 46(4): 450-457. DOI: 10.11665/j.issn.1000-5048.20150411
    [7]ZHANG Lu, QIANG Shuping, ZHANG Yunjing, WANG Lei, ZHANG Xiaofei, HANG Taijun. Preliminary identification of the related substances in cisatracurium besylate for injection by LC-MS[J]. Journal of China Pharmaceutical University, 2013, 44(1): 65-72. DOI: 10.11665/j.issn.1000-5048.20130111
    [8]KONG Xing-xin, SHEN Wen-bin, WANG Li-yun, SHI Jin-fang, DI Bin, ZHANG Tao. Identification of the related substances in cefmetazole sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2012, 43(2): 170-176.
    [9]QIN Fang, DING Ya, HANG Tai-jun, SONG Min. Identification of the related substances in faropenem sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2011, 42(4): 342-347.
    [10]TIAN Yuan, FENG Shu-dan, HUANG Mei-hua, ZHANG Zun-jian. LC-MS/MS determination of glucocorticoids illegally added into cosmetics[J]. Journal of China Pharmaceutical University, 2011, 42(1): 53-57.

  • Cited by

    Periodical cited type(2)

    1. 王圆超，赵辉，王月，谷岩翡，高月麒，李晓露. 他克莫司的分离提纯研究. 中国抗生素杂志. 2024(02): 175-180 .
    2. 楚士颖，周玉松，张怡铭，唐雨晴，朱思宇，程文播. 液相色谱-串联质谱法同时测定血清中四种免疫抑制剂的药物浓度. 中国当代医药. 2024(09): 7-10+15 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (1410) PDF downloads (1158) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：309727

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return